SARS-CoV-2 nsp14-IN-1 (Compound 3) is a potent dual-substrate inhibitor of SARS-CoV-2 Nsp14 methyltransferase (MTase) with an IC50 value of 0.061 μM; it exhibits high selectivity over human methyltransferases, showing negligible activity against a panel of 10 human methyltransferases involved in histone lysine, protein arginine, DNA, and RNA methylation.